$NEXI NexImmune, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NexImmune, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NexImmune, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in NexImmune, Inc. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NEXI
Company Address: 9119 GAITHER ROAD GAITHERSBURG 20878
Phone number: 301-825-9810
NexImmune, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | NEXI | NexImmune, Inc. | Trainer John | Chief Financial Off ... | Option Exercise | M | 5.17 | 3,432 | 17,743 | 116,677 | |
| Mar 12 2021 | NEXI | NexImmune, Inc. | Trainer John | Chief Financial Off ... | Buy | M | 5.17 | 3,432 | 17,743 | 48,042 | 44.6 K to 48 K (+7.69 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Option Exercise | C | 0.00 | 14,738 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Buy | P | 17.00 | 911 | 15,487 | 63,078 | 62.2 K to 63.1 K (+1.47 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Buy | C | 0.00 | 14,738 | 0 | 62,167 | 47.4 K to 62.2 K (+31.07 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 26,590 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 4,110 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 85,016 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 12,268 | 0 | 127,984 | 115.7 K to 128 K (+10.60 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 26,590 | 0 | 115,716 | 89.1 K to 115.7 K (+29.83 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 4,110 | 0 | 89,126 | 85 K to 89.1 K (+4.83 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 85,016 | 0 | 85,016 | 0 to 85 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Verstandig Grant | Director | Buy | P | 17.00 | 175,000 | 2,975,000 | 714,895 | 539.9 K to 714.9 K (+32.41 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Verstandig Grant | Director | Buy | C | 0.00 | 539,895 | 0 | 539,895 | 0 to 539.9 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | C | 0.00 | 4,110 | 0 | 0 |